Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Poulter

Showing results (121-130 of 179) with videos related to

Pageof 18
Sort By:
Journal of the American Society of Nephrology : JASN|May 16, 2009
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetesToshiharu Ninomiya, Vlado Perkovic, Bastiaan E de Galan, et al.
Diabetes, Obesity & Metabolism|March 22, 2023
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trialDarren K McGuire, Rodica P Busui, John Deanfield, et al.
Global Heart|February 19, 2024
Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of HypertensionAnthony Rodgers, Abdul Salam, William Cushman, et al.
American Heart Journal|April 30, 2017
Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)Robert J Mentz, M Angelyn Bethel, Stephanie Gustavson, et al.
BMC Cardiovascular Disorders|May 23, 2021
High prevalence of non-dipping patterns among Black Africans with uncontrolled hypertension: a secondary analysis of the CREOLE trialProssie Merab Ingabire, Dike B Ojji, Brian Rayner, et al.
Diabetes Care|August 5, 2009
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trialSophia Zoungas, Bastiaan E de Galan, Toshiharu Ninomiya, et al.
Journal of the American Society of Nephrology : JASN|February 20, 2009
Lowering blood pressure reduces renal events in type 2 diabetesBastiaan E de Galan, Vlado Perkovic, Toshiharu Ninomiya, et al.
Hypertension (Dallas, Tex. : 1979)|September 2, 2022
Effect of 3, 2-Drug Combinations of Antihypertensive Therapies on Blood Pressure Variability in Black African Patients: Secondary Analyses of the CREOLE TrialDike B Ojji, Victoria Cornelius, Giles Partington, et al.
The New England Journal of Medicine|March 19, 2019
Comparison of Dual Therapies for Lowering Blood Pressure in Black AfricansDike B Ojji, Bongani Mayosi, Veronica Francis, et al.
International Journal of Cardiology|January 7, 2016
Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countriesRuth Webster, Anushka Patel, Vanessa Selak, et al.
Pageof 18

Showing results (121-130 of 179) with videos related to

Sort By:
Pageof 18
Journal of the American Society of Nephrology : JASN|May 16, 2009
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetesToshiharu Ninomiya, Vlado Perkovic, Bastiaan E de Galan, et al.
Diabetes, Obesity & Metabolism|March 22, 2023
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trialDarren K McGuire, Rodica P Busui, John Deanfield, et al.
Global Heart|February 19, 2024
Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of HypertensionAnthony Rodgers, Abdul Salam, William Cushman, et al.
American Heart Journal|April 30, 2017
Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)Robert J Mentz, M Angelyn Bethel, Stephanie Gustavson, et al.
BMC Cardiovascular Disorders|May 23, 2021
High prevalence of non-dipping patterns among Black Africans with uncontrolled hypertension: a secondary analysis of the CREOLE trialProssie Merab Ingabire, Dike B Ojji, Brian Rayner, et al.
Diabetes Care|August 5, 2009
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trialSophia Zoungas, Bastiaan E de Galan, Toshiharu Ninomiya, et al.
Journal of the American Society of Nephrology : JASN|February 20, 2009
Lowering blood pressure reduces renal events in type 2 diabetesBastiaan E de Galan, Vlado Perkovic, Toshiharu Ninomiya, et al.
Hypertension (Dallas, Tex. : 1979)|September 2, 2022
Effect of 3, 2-Drug Combinations of Antihypertensive Therapies on Blood Pressure Variability in Black African Patients: Secondary Analyses of the CREOLE TrialDike B Ojji, Victoria Cornelius, Giles Partington, et al.
The New England Journal of Medicine|March 19, 2019
Comparison of Dual Therapies for Lowering Blood Pressure in Black AfricansDike B Ojji, Bongani Mayosi, Veronica Francis, et al.
International Journal of Cardiology|January 7, 2016
Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countriesRuth Webster, Anushka Patel, Vanessa Selak, et al.
Pageof 18